Hagel Alexander F, Albrecht Heinz, Nägel Andreas, Vitali Francesco, Vetter Marcel, Dauth Christine, Neurath Markus F, Raithel Martin
Department of Gastroenterology, University of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
Institute for Employment Research, Regensburger Straße 104, 90478 Nuremberg, Germany.
Gastroenterol Res Pract. 2017;2017:3083481. doi: 10.1155/2017/3083481. Epub 2017 Jan 23.
. Gastrointestinal bleeding represents the main indication for emergency endoscopy (EE). Lately, several hemostatic powders have been released to facilitate EE. . We evaluated all EE in which Hemospray was used as primary or salvage therapy, with regard to short- and long-term hemostasis and complications. . We conducted 677 EE in 474 patients (488 examinations in 344 patients were upper GI endoscopies). Hemospray was applied during 35 examinations in 27 patients (19 males), 33 during upper and 2 during lower endoscopy. It was used after previous treatment in 21 examinations (60%) and in 14 (40%) as salvage therapy. Short-term success was reached in 34 of 35 applications (97.1%), while long-term success occurred in 23 applications (65.7%). Similar long-term results were found after primary application (64,3%) or salvage therapy (66,7%). Rebleeding was found in malignant and extended ulcers. One major adverse event (2.8%) occurred with gastric perforation after Hemospray application. . Hemospray achieved short-term hemostasis in virtually all cases. The long-term effect is mainly determined by the type of bleeding source, but not whether it was applied as first line or salvage therapy. But, even in the failures, patients had benefit from hemodynamic stabilization and consecutive interventions in optimized conditions.
胃肠道出血是急诊内镜检查(EE)的主要指征。最近,有几种止血粉已上市以方便进行急诊内镜检查。我们评估了所有将Hemospray用作主要或挽救治疗的急诊内镜检查,观察其短期和长期止血效果及并发症情况。我们对474例患者进行了677次急诊内镜检查(344例患者进行了488次上消化道内镜检查)。在27例患者(19例男性)的35次检查中应用了Hemospray,其中上消化道内镜检查33次,下消化道内镜检查2次。在21次检查(60%)中,它在先前治疗后使用,在14次检查(40%)中作为挽救治疗使用。35次应用中有34次(97.1%)取得了短期成功,23次应用(65.7%)取得了长期成功。初次应用(64.3%)或挽救治疗(66.7%)后发现了相似的长期结果。在恶性溃疡和巨大溃疡中发现有再出血情况。应用Hemospray后发生1例主要不良事件(2.8%),为胃穿孔。Hemospray在几乎所有病例中都实现了短期止血。长期效果主要取决于出血源的类型,而不是它是作为一线治疗还是挽救治疗应用。但是,即使在治疗失败的情况下,患者也从血流动力学稳定及在优化条件下的后续干预中获益。